Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study (Q38839775)

6 September 2017

0 references

Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study (English)

1 reference

6 September 2017

0 references

1 reference

1 reference

31

Sabine Tejpar

0 references

Emily Rayner

Emily Rayner

3

0 references

Arnoud Boot

Arnoud Boot

9

0 references

David N Church

David N Church

36

0 references

David Kerr

David Kerr

34

0 references

Enric Domingo

Enric Domingo

1

0 references

Viktor H. Koelzer

Viktor H Koelzer

19

0 references

Ragnhild A. Lothe

13

Ragnhild A Lothe

1 reference

6 September 2017

35

Ian Tomlinson

1 reference

6 September 2017

16

Arild Nesbakken

1 reference

6 September 2017

14

Stine A Danielsen

1 reference

6 September 2017

15

Anita Sveen

1 reference

6 September 2017

Luke Freeman-Mills

2

1 reference

6 September 2017

Mark Glaire

4

1 reference

6 September 2017

Sarah Briggs

5

1 reference

6 September 2017

Louis Vermeulen

6

1 reference

6 September 2017

Evelyn Fessler

7

1 reference

6 September 2017

Jan Paul Medema

8

1 reference

6 September 2017

Hans Morreau

10

1 reference

6 September 2017

Tom van Wezel

11

1 reference

6 September 2017

Gerrit-Jan Liefers

12

1 reference

6 September 2017

Inti Zlobec

17

1 reference

6 September 2017

Alessandro Lugli

18

1 reference

6 September 2017

Martin D Berger

20

1 reference

6 September 2017

Sergi Castellví-Bel

21

1 reference

6 September 2017

Jenifer Muñoz

22

1 reference

6 September 2017

Epicolon consortium

23

1 reference

6 September 2017

Marco de Bruyn

24

1 reference

6 September 2017

Hans W Nijman

25

1 reference

6 September 2017

Marco Novelli

26

1 reference

6 September 2017

Kay Lawson

27

1 reference

6 September 2017

Dahmane Oukrif

28

1 reference

6 September 2017

Eleni Frangou

29

1 reference

6 September 2017

Peter Dutton

30

1 reference

6 September 2017

Mauro Delorenzi

32

1 reference

6 September 2017

Rachel Kerr

33

1 reference

6 September 2017

20 July 2016

1 reference

The lancet. Gastroenterology & hepatology

6 September 2017

1 reference

6 September 2017

1

1 reference

6 September 2017

207-216

1 reference

6 September 2017

3

1 reference

From human genome to cancer genome: the first decade

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Precision Oncology: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Integrated genomic characterization of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Comprehensive molecular characterization of human colon and rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

A panoply of errors: polymerase proofreading domain mutations in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Yeast DNA polymerase epsilon participates in leading-strand DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Signatures of mutational processes in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Prognostic significance of POLE proofreading mutations in endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Genetic susceptibility variants associated with colorectal cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Individual participant data meta-analysis of prognostic factor studies: state of the art?

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

The consensus molecular subtypes of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Systematic review of microsatellite instability and colorectal cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Genetic basis for clinical response to CTLA-4 blockade in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930014-0

7 January 2021

10.1016/S2468-1253(16)30014-0

Identifiers

DOI

1 reference

6 September 2017

1 reference